David Katz Gilead Sciences, Inc. Transaction History

Matrix Asset Advisors Inc

$835 Million
Q1 2024

A detailed history of David Katz (Matrix Asset Advisors Inc) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Matrix Asset Advisors Inc holds 311,545 shares of GILD stock, worth $21.1 Million. This represents 2.73% of its overall portfolio holdings.

Number of Shares

311,545

Previous 297,345 4.78%

Holding current value

$21.1 Million

Previous $24.1 Million 5.26%

% of portfolio

2.73%

Previous 3.07%

40 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$71.58 - $87.29 $1.02 Million - $1.24 Million	14,200 Added 4.78%	311,545 $22.8 Million
Q4 2023 Jan 24, 2024	SELL	$73.27 - $83.09 $476,914 - $540,832	-6,509 Reduced 2.14%	297,345 $24.1 Million
Q3 2023 Oct 12, 2023	BUY	$73.94 - $80.67 $230,914 - $251,932	3,123 Added 1.04%	303,854 $22.8 Million
Q2 2023 Jul 18, 2023	SELL	$76.01 - $86.7 $1.66 Million - $1.9 Million	-21,894 Reduced 6.79%	300,731 $23.2 Million
Q1 2023 Apr 13, 2023	BUY	$77.31 - $88.08 $444,764 - $506,724	5,753 Added 1.82%	322,625 $26.8 Million

Q4 2022 Jan 19, 2023	SELL	$62.32 - $89.47 $696,737 - $1 Million	-11,180 Reduced 3.41%	316,872 $0
Q3 2022 Oct 24, 2022	BUY	$59.54 - $68.01 $9.59 Million - $11 Million	161,043 Added 96.43%	328,052 $20.2 Million
Q2 2022 Jul 15, 2022	SELL	$57.72 - $65.01 $11.3 Million - $12.7 Million	-195,980 Reduced 53.99%	167,009 $10.3 Million
Q1 2022 Apr 22, 2022	BUY	$57.92 - $72.58 $1.96 Million - $2.45 Million	33,818 Added 10.27%	362,989 $21.6 Million
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $1.46 Million - $1.65 Million	-22,445 Reduced 6.38%	329,171 $23.9 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $110,470 - $119,184	1,632 Added 0.47%	351,616 $24.6 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $46,396 - $50,694	-731 Reduced 0.21%	349,984 $24.1 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $3.03 Million - $3.45 Million	50,430 Added 16.79%	350,715 $22.7 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $1.38 Million - $1.57 Million	24,354 Added 8.83%	300,285 $17.5 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $1.47 Million - $1.85 Million	23,702 Added 9.4%	275,931 $17.4 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $2.93 Million - $3.41 Million	-40,551 Reduced 13.85%	252,229 $19.4 Million
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $1.92 Million - $2.46 Million	-30,646 Reduced 9.48%	292,780 $21.9 Million
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $1.96 Million - $2.15 Million	31,727 Added 10.88%	323,426 $21 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $817,630 - $902,520	13,080 Added 4.69%	291,699 $18.5 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $1.13 Million - $1.27 Million	-18,257 Reduced 6.15%	278,619 $18.8 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $940,201 - $1.05 Million	15,036 Added 5.33%	296,876 $19.3 Million
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $208,499 - $272,076	3,444 Added 1.24%	281,840 $17.6 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $646,794 - $716,120	9,074 Added 3.37%	278,396 $21.5 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $1.3 Million - $1.52 Million	20,046 Added 8.04%	269,322 $19.1 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $696,423 - $849,016	9,561 Added 3.99%	249,276 $18.8 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $1.15 Million - $1.35 Million	16,178 Added 7.24%	239,715 $17.2 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1,946 - $2,307	27 Added 0.01%	223,537 $18.1 Million
Q2 2017 Aug 09, 2017	BUY	N/A	8,815 Added 4.11%	223,510 $15.8 Million
Q1 2017 May 10, 2017	BUY	N/A	16,632 Added 8.4%	214,695 $14.6 Million
Q4 2016 Feb 08, 2017	BUY	N/A	13,104 Added 7.08%	198,063 $14.2 Million
Q3 2016 Nov 07, 2016	BUY	N/A	29,174 Added 18.73%	184,959 $14.6 Million
Q2 2016 Aug 03, 2016	BUY	N/A	23,901 Added 18.12%	155,785 $13 Million
Q1 2016 May 05, 2016	BUY	N/A	10,643 Added 8.78%	131,884 $12.1 Million
Q4 2015 Feb 08, 2016	SELL	N/A	-50,678 Reduced 29.48%	121,241 $12.3 Million
Q3 2015 Nov 10, 2015	BUY	N/A	7,340 Added 4.46%	171,919 $16.9 Million
Q2 2015 Aug 07, 2015	SELL	N/A	-11,486 Reduced 6.52%	164,579 $19.3 Million
Q1 2015 May 08, 2015	BUY	N/A	119,166 Added 209.43%	176,065 $17.3 Million
Q4 2014 Feb 10, 2015	BUY	N/A	13,793 Added 32.0%	56,899 $5.36 Million
Q3 2014 Nov 06, 2014	BUY	N/A	250 Added 0.58%	43,106 $4.59 Million
Q2 2014 Aug 11, 2014	BUY	N/A	42,856	42,856 $3.55 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.9B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track David Katz's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Asset Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Asset Advisors Inc and David Katz with notifications on news.

Account